Book Value per Share: hepionpharma.com (HEPA)

Graphic logo of Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals management is focusing on conducting clinical trials of liver drugs. These developments rely on an AI ecosystem for genomic analysis, which creates a closed patent perimeter. Accounting data on the share price visualize equity minus debt, where the 0.23 level captures the current state. Expectations for early-stage therapy results and liquidity risks are already priced into the market quote.

Hepion Pharma (HEPA): Share Book Value from 07/04/2022 to 06/14/2025

Hepion Pharmaceuticals Inc. - analytical breakdowns and key metrics (HEPA)

- price and consensus price forecast:
Price Chart Hepion Pharma|HEPA - Forecast Levels Chart
- market capitalization data:
Market Capitalization Hepion Pharmaceuticals, Inc.|HEPA - Enterprise Value
- book capitalization data:
Net Assets per Single Share Hepion Pharmaceuticals|HEPA - Net Asset Value|Market Capitalization to Book Value Ratio hepionpharma.com|HEPA - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Hepion Pharmaceuticals|HEPA - Long-Term Debt to Capital|Short-Term Debt to Equity Hepion Pharma|HEPA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Hepion Pharmaceuticals, Inc.|HEPA - Company Long-Term Liabilities|Company Short-Term Debts Hepion Pharmaceuticals
Fundamental company valuation:hepionpharma.com - HEPA
Manufactured products of Hepion Pharma

When constructing a long-term portfolio, fundamental screening requires an assessment of the real value of assets minus all liabilities. This indicator measures the equity per share, reflecting the intrinsic value of the business, which for Hepion Pharmaceuticals (HEPA), with its bioinformatics platform and clinical developments, confirms the capitalization of innovations into the final book value per share.

Competitors of Hepion Pharmaceuticals (HEPA)

Net Assets per Single Share Arrowhead Pharmaceuticals Inc|MIRM - Share Book Value|DVAX: Book Value per Share|ABUS (arbutusbio.com) - Book Value per Share|Net Assets per Single Share Inventiva IVA|Share Book Value Gyre Therapeutics Inc|Assembly Biosciences Inc (ASMB) - Book Value per Share|Accounting Value of a Share galectintherapeutics.com (GALT)|Book Value per Share GNFT (GENFIT)|DURECT Corp - Book Value per Share|Net Assets per Single Share Aligos (ALGS)|BIVI: Accounting Value of a Share|GLMD (galmedpharma.com) - Net Assets per Single Share|ENDRA Corp (NDRA) - Accounting Value per Share